Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vaccinia-related kinase 1 (VRK1)
- Target
- VRK1
- Molecular classification
- Enzyme, Ser/Thr protein kinase
01
Overview
Vaccinia-related kinase 1 (VRK1) is a serine/threonine protein kinase involved in cell cycle regulation, nuclear envelope assembly, transcriptional regulation, and DNA damage response. It stabilizes and activates p53, and its overexpression is associated with poor prognosis in several cancers, including hepatocellular carcinoma. VRK1 is considered a potential therapeutic target for cancer and proliferative diseases.
- Other names
- PCH1PCH1Avaccinia related kinase 1VRK serine/threonine kinase 1
02
Mechanism of action
Small-molecule inhibition of kinase activity (in development)
03
Biological functions
Cell cycle regulationNuclear envelope assemblyTranscriptional regulationDNA damage responseCell proliferation
04
Disease associations
Cancer
05
Safety considerations
Potential for off-target effects due to kinase family similaritiesInhibition may disrupt normal cell cycle and DNA repair processes
06
Biomarkers
VRK1 expression levels as prognostic biomarker in cancer (e.g., HCC)
Beyond the preview
Go deeper on Vaccinia-related kinase 1 (VRK1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vaccinia-related kinase 1 (VRK1).